Terms: = Prostate cancer AND FOXO4, P98177, 4303, ENSG00000184481, MLLT7, AFX1
13 results:
1. circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.
Ding L; Wang R; Zheng Q; Shen D; Wang H; Lu Z; Luo W; Xie H; Ren L; Jiang M; Yu C; Zhou Z; Lin Y; Lu H; Xue D; Su W; Xia L; Neuhaus J; Cheng S; Li G
J Exp Clin Cancer Res; 2022 Jun; 41(1):187. PubMed ID: 35650605
[TBL] [Abstract] [Full Text] [Related]
2. [Expression of forkhead transcription factor O4 in prostate cancer and its effect on prostate cancer cell invasion].
Huang F; Li X; Du Q; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1194-1201. PubMed ID: 30643063
[TBL] [Abstract] [Full Text] [Related]
3. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells.
Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C
Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376
[TBL] [Abstract] [Full Text] [Related]
4. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote prostate Tumorigenesis and Cell Invasion.
Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
[TBL] [Abstract] [Full Text] [Related]
5. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
Lin CL; Chen CM; Lin CL; Cheng CW; Lee CH; Hsieh YH
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1867-1876. PubMed ID: 28760656
[TBL] [Abstract] [Full Text] [Related]
6. GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer.
Su W; Li S; Chen X; Yin L; Ma P; Ma Y; Su B
Oncotarget; 2017 Jan; 8(3):4449-4459. PubMed ID: 27966458
[TBL] [Abstract] [Full Text] [Related]
7. A genome-wide RNAi screen identifies foxo4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer.
Su B; Gao L; Baranowski C; Gillard B; Wang J; Ransom R; Ko HK; Gelman IH
PLoS One; 2014; 9(7):e101411. PubMed ID: 24983969
[TBL] [Abstract] [Full Text] [Related]
8. Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.
Zaravinos A; Kanellou P; Lambrou GI; Spandidos DA
Tumour Biol; 2014 May; 35(5):4987-5005. PubMed ID: 24481661
[TBL] [Abstract] [Full Text] [Related]
9. Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations.
Fachel AA; Tahira AC; Vilella-Arias SA; Maracaja-Coutinho V; Gimba ER; Vignal GM; Campos FS; Reis EM; Verjovski-Almeida S
Mol Cancer; 2013 Nov; 12(1):140. PubMed ID: 24238219
[TBL] [Abstract] [Full Text] [Related]
10. Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice.
Shukla S; Bhaskaran N; Maclennan GT; Gupta S
Prostate; 2013 Oct; 73(14):1507-17. PubMed ID: 23765843
[TBL] [Abstract] [Full Text] [Related]
11. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells.
Chen Q; Ganapathy S; Singh KP; Shankar S; Srivastava RK
PLoS One; 2010 Dec; 5(12):e15288. PubMed ID: 21179458
[TBL] [Abstract] [Full Text] [Related]
12. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
Liu P; Kao TP; Huang H
Oncogene; 2008 Aug; 27(34):4733-44. PubMed ID: 18408765
[TBL] [Abstract] [Full Text] [Related]
13. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores.
Berger AP; Gozzi C; Steiner H; Frauscher F; Varkarakis J; Rogatsch H; Bartsch G; Horninger W
J Urol; 2004 Apr; 171(4):1478-80; discussion 1480-1. PubMed ID: 15017202
[TBL] [Abstract] [Full Text] [Related]
